The Department of Health and the Medicines and Healthcare products Regulatory Agency (MHRA) do not routinely collect information on websites advertising botulinum toxin, fillers and other non-surgical cosmetic procedures for sale to people in the United Kingdom.
However, the MHRA regulates the advertising of medicines, including botulinum toxin products where it is a licensed medicine. The cosmetic use of Botox® is outside the product’s licensed indications. The administration of injectable medicines such as Botox® (whether or not for cosmetic use) is restricted. Unless self-administered, they may only be administered by an independent practitioner or a person acting in accordance with the patient-specific directions of an independent prescriber. The MHRA will take appropriate action on receipt of any complaint about websites advertising botulinum toxin as a cosmetic treatment.